Radimetrics Enterprise Platform Crafted for the Smaller Institution
By MedImaging International staff writers Posted on 15 Mar 2016 |
Radimetrics Enterprise Platform is again the highlight of the European Congress of Radiology (ECR) but this year it has a new twist, or in the words of Mr. Bill Cavanaugh, Head of Global Informatics Strategy at Bayer Pharma Radiology (Whippany NJ), “Radimetrics, with our new Select Package, is a simple, affordable and scalable solution to help smaller institutions prepare for regulation while improving the performance of their radiology practices.”
Bill Cavanaugh continued by explaining that Bayer Pharma Radiology had introduced a new version of the platform that helps radiologists manage radiation exposure by mitigating inefficiencies and achieving reproducible quality. It is used alongside MRI to monitor contrast dose, and in CT imaging, X-ray, interventional medicine, nuclear medicine and mammography to monitor radiation dose. It comes with tools to not only monitor radiation and contrast dose from scanners and injectors, but enables the physician to manage patient dose history longitudinally.
“Now we have a version of the product incorporating the specific needs of the smaller end of the market,” said Mr. Cavanaugh, explaining some of the benefits of this new version of the product. “We have brought in all of the best practices from leading healthcare institutions to transform our contrast injectors into smart connected devices within the broader hospital ecosystem, bringing efficiencies and patient-centered care to even the smallest users.”
This latest version of Radimetrics also encompasses efforts to bring some of the best teaching practices from large teaching hospitals to the benefit of smaller practices. Registries are one of the latest initiatives to allow small institutions to benchmark themselves against what leading institutions. Mr. Cavanaugh cites the example of a registry being established in Germany currently. “In Germany, a new registry is under formation and we can potentially compare data from an institution in Switzerland with data from a leader in Germany, as well as connecting them with what is happening in California, for example. It’s about sharing best practices.”
Asked about the challenges associated with bringing a complex platform to the smaller institution, he added that it was a challenge that manifested in the art of software creation. Streamlining this complexity into a digestible format is done through the use of customizable dashboards that are preconfigured. “We’ve taken our learnings over recent years and simplified that down to five concise dashboards that are preconfigured with alerts that a small institution can use. If these institutions want to grow to more advanced capability then they can do that,” he pointed out.
One of the main benefits of Radimetrics is the radiation dose management and it provides data required by the upcoming European directive. Another key feature of the product is the level of quality that customers buy into. “Quality is not a one-time event but a continuous process,” asserted Mr. Cavanaugh. “Generally, in radiology people are being forced to do more with less—more compliance, more needs, more pressure to put more patients through the scanner. This product helps with efficiency.”
“It’s about quality, continuous improvement, patient safety and giving the physician time to focus on the patient because the software can be used intuitively and seamlessly.”
Related Links:
Bayer Pharma Radiology
Bill Cavanaugh continued by explaining that Bayer Pharma Radiology had introduced a new version of the platform that helps radiologists manage radiation exposure by mitigating inefficiencies and achieving reproducible quality. It is used alongside MRI to monitor contrast dose, and in CT imaging, X-ray, interventional medicine, nuclear medicine and mammography to monitor radiation dose. It comes with tools to not only monitor radiation and contrast dose from scanners and injectors, but enables the physician to manage patient dose history longitudinally.
“Now we have a version of the product incorporating the specific needs of the smaller end of the market,” said Mr. Cavanaugh, explaining some of the benefits of this new version of the product. “We have brought in all of the best practices from leading healthcare institutions to transform our contrast injectors into smart connected devices within the broader hospital ecosystem, bringing efficiencies and patient-centered care to even the smallest users.”
This latest version of Radimetrics also encompasses efforts to bring some of the best teaching practices from large teaching hospitals to the benefit of smaller practices. Registries are one of the latest initiatives to allow small institutions to benchmark themselves against what leading institutions. Mr. Cavanaugh cites the example of a registry being established in Germany currently. “In Germany, a new registry is under formation and we can potentially compare data from an institution in Switzerland with data from a leader in Germany, as well as connecting them with what is happening in California, for example. It’s about sharing best practices.”
Asked about the challenges associated with bringing a complex platform to the smaller institution, he added that it was a challenge that manifested in the art of software creation. Streamlining this complexity into a digestible format is done through the use of customizable dashboards that are preconfigured. “We’ve taken our learnings over recent years and simplified that down to five concise dashboards that are preconfigured with alerts that a small institution can use. If these institutions want to grow to more advanced capability then they can do that,” he pointed out.
One of the main benefits of Radimetrics is the radiation dose management and it provides data required by the upcoming European directive. Another key feature of the product is the level of quality that customers buy into. “Quality is not a one-time event but a continuous process,” asserted Mr. Cavanaugh. “Generally, in radiology people are being forced to do more with less—more compliance, more needs, more pressure to put more patients through the scanner. This product helps with efficiency.”
“It’s about quality, continuous improvement, patient safety and giving the physician time to focus on the patient because the software can be used intuitively and seamlessly.”
Related Links:
Bayer Pharma Radiology
Latest Imaging IT News
- New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
- Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
- AI-Based Mammography Triage Software Helps Dramatically Improve Interpretation Process
- Artificial Intelligence (AI) Program Accurately Predicts Lung Cancer Risk from CT Images
- Image Management Platform Streamlines Treatment Plans
- AI-Based Technology for Ultrasound Image Analysis Receives FDA Approval
- AI Technology for Detecting Breast Cancer Receives CE Mark Approval
- Digital Pathology Software Improves Workflow Efficiency
- Patient-Centric Portal Facilitates Direct Imaging Access
- New Workstation Supports Customer-Driven Imaging Workflow
Channels
Radiography
view channel
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read more
AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
Percutaneous coronary intervention (PCI), also known as coronary angioplasty, is a minimally invasive procedure where small metal tubes called stents are inserted into partially blocked coronary arteries... Read moreMRI
view channel
AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more
Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
Approximately 360,000 individuals in the UK suffer from focal epilepsy, a condition in which seizures spread from one part of the brain. Around a third of these patients experience persistent seizures... Read more
AI-Powered MRI Technology Improves Parkinson’s Diagnoses
Current research shows that the accuracy of diagnosing Parkinson’s disease typically ranges from 55% to 78% within the first five years of assessment. This is partly due to the similarities shared by Parkinson’s... Read more
Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
Artificial intelligence (AI) technologies are transforming the way medical images are analyzed, offering unprecedented capabilities in quantitatively extracting features that go beyond traditional visual... Read moreUltrasound
view channel
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read more
Novel Imaging Method Enables Early Diagnosis and Treatment Monitoring of Type 2 Diabetes
Type 2 diabetes is recognized as an autoimmune inflammatory disease, where chronic inflammation leads to alterations in pancreatic islet microvasculature, a key factor in β-cell dysfunction.... Read moreNuclear Medicine
view channel
Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
COX-2, an enzyme that plays a key role in brain inflammation, can be significantly upregulated by inflammatory stimuli and neuroexcitation. Researchers suggest that COX-2 density in the brain could serve... Read more
Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC), which represents 15-20% of all breast cancer cases, is one of the most aggressive subtypes, with a five-year survival rate of about 40%. Due to its significant heterogeneity... Read moreGeneral/Advanced Imaging
view channel
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
AI Model Significantly Enhances Low-Dose CT Capabilities
Lung cancer remains one of the most challenging diseases, making early diagnosis vital for effective treatment. Fortunately, advancements in artificial intelligence (AI) are revolutionizing lung cancer... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more